Chemotherapy-related cognitive impairment (CRCI), especially subjective cognitive complaints (SCC), had been often reported in breast cancer survivors, which affects their life and work. The identification of biomarkers for early diagnosis and prognosis prediction of SCC remains a crucial challenge of important clinical implications. The resting-state functional magnetic resonance imaging (rs-fMRI) has been widely used to detect abnormalities of brain activity in CRCI. The machine learning method combined with rs-fMRI features could effectively identify breast cancer survivors with chemotherapy-related SCC from healthy controls (HC).
How to access this content:
For one year after publication, abstracts and videos are only open to registrants of this annual meeting. Registrants should use their existing login information. Non-registrant access can be purchased via the ISMRM E-Library.
After one year, current ISMRM & ISMRT members get free access to both the abstracts and videos. Non-members and non-registrants must purchase access via the ISMRM E-Library.
After two years, the meeting proceedings (abstracts) are opened to the public and require no login information. Videos remain behind password for access by members, registrants and E-Library customers.
Keywords